First-Ever Human Trials For Experimental Drug To Begin Soon

September 2, 2014 7:41 AM

14 0

First-Ever Human Trials For Experimental Drug To Begin Soon

An experimental Ebola vaccine developed by GlaxoSmithKline plc (NYSE:GSK) in collaboration with the National Institute of Allergy and Infectious Diseases, or NIAID, will be tested on human volunteers later this week, according to a statement published on the National Institutes of Health, or NIH, website.

The experimental vaccine will be administered to a small group of volunteers aged 18 to 50 at the NIH Clinical Center in Maryland where they will be closely monitored for adverse effects, the statement said. Considering the magnitude and severity of the current Ebola outbreak, which is the deadliest...

Read more

To category page

Loading...